<PAGE>

                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM S-8

                        REGISTRATION STATEMENT UNDER THE
                             SECURITIES ACT OF 1933

                               NuWay Medical, Inc.
            --------------------------------------------------------
             (Exact Name of Registrant as Specified in its Charter)



           Delaware                                 65-0159115
-----------------------------------          -------------------------
 (State or Other Jurisdiction of                 (IRS Employer
  Incorporation or  Organization)              Identification No.)



     23461 South Pointe Drive, Suite 200, Laguna Hills, California      92653
--------------------------------------------------------------------------------
     (Address of Principal Executive Offices)                        (Zip Code)


                           2002 Consultant Equity Plan
--------------------------------------------------------------------------------
                            (Full Title of the Plan)

                                 Dennis Calvert
                       23461 South Pointe Drive, Suite 200
                         Laguna Hills, California  92653
--------------------------------------------------------------------------------
                     (Name and Address of Agent for Service)

                                  949.454.9011
--------------------------------------------------------------------------------
          (Telephone Number, Including Area Code, of Agent for Service)


                         CALCULATION OF REGISTRATION FEE
================================================================================

Title  of  Each                     Proposed       Proposed
   Class of                         Maximum        Maximum
  Securities         Amount         Offering      Aggregate         Amount of
    To Be             To Be          Price         Offering       Registration
  Registered        Registered      Per Unit         Price             Fee
--------------------------------------------------------------------------------

Common  Stock       3,500,000(1)    $0.13(2)      $455,000(2)         $126.49
--------------------------------------------------------------------------------

(1)  The  number  of shares of securities covered by this Registration Statement
will  be  increased  as  a  result  of  adjustments  to the registrant's capital
structure  resulting  from  any  future  stock  split, stock dividend or similar
adjustment  to  the  registrant's  outstanding  common  stock.

(2)  Estimated  pursuant  to Rule 457(c) promulgated under the Securities Act of
1933,  as  amended,  solely  for  purpose  of  calculating  the  amount  of  the
registration  fee,  based  upon  the  average  of  the  bid and ask price of the
registrant's  common stock as reported on the NASDAQ Small Capitalization market
reporting  system  on  December  20,  2002.

<PAGE>
                                EXPLANATORY NOTE
                      REGISTRATION OF ADDITIONAL SECURITIES

     NuWay  Medical,  Inc.  (referred  to  as  "We"  or  the  like  or  as the
"Registrant")  is  filing  this  Registration  Statement in order to register an
additional  3,500,000  shares  of  its  common  stock.  We  previously  filed  a
registration  statement  on  Form  S-8  (the  "Initial  Registration Statement")
covering  1,500,000 shares of our common stock that are issuable pursuant to our
2002  Consultant  Equity  Plan  (the  "Plan").  This  amendment  to  the Initial
Registration  Statement  is  being  made  in  order  to  register  an additional
3,500,000  common  shares  that  our  Board of Directors authorized to be issued
under  the  Plan.  As  a  result  of  this  Registration  Statement,  a total of
5,000,000  common  shares  authorized to be issued under the Plan are covered by
filings  we  have  made  on  Form  S-8,  including  this Registration Statement.

     The  contents  of  the  Initial  Registration  Statement,  filed  with  the
Securities  and Exchange Commission (the "Commission") on August 8, 2002, as SEC
file  number  333-97839,  are  incorporated  by reference into this Registration
Statement.


                                     PART II
                           INFORMATION REQUIRED IN THE
                             REGISTRATION STATEMENT


ITEM  3.  INCORPORATION  OF  DOCUMENTS  BY  REFERENCE.

     The  following  documents  are  hereby  incorporated by reference into this
registration  statement:


1.   The Registrant's Annual Report on Form 10-KSB for the fiscal year ended
     December 31, 2001, which the Registrant filed with the Commission on April
     12, 2002;

2.   The Registrant's Current Report on Form 8-K, which the Registrant filed
     with the Commission on January 29, 2002;

3.   The Registrant's Current Report on Form 8-K, which the Registrant filed
     with the Commission on February 22, 2002;

4.   The Registrant's Current Report on Form 8-K, which the Registrant filed
     with the Commission on March 6, 2002;

5.   The Registrant's Current Report on Form 8-K, which the Registrant filed
     with the Commission on March 8, 2002;

6.   The Registrant's Current Report on Form 8-K, which the Registrant filed
     with the Commission on March 12, 2002;


                                      -2-

<PAGE>

7.   The Registrant's Amended Annual Report on Form 10-KSB/A-1 for the fiscal
     year ended December 31, 2000, which the Registrant filed with the
     Commission on March 20, 2002;

8.   The Registrant's Amended Quarterly Report on Form 10-QSB/A-1 for the fiscal
     quarter ended September 30, 2001, which the Registrant filed with the
     Commission on March 25, 2002;

9.   The Registrant's Amended Quarterly Report on Form 10-QSB/A-1 for the fiscal
     year ended June 30, 2001, which the Registrant filed with the Commission on
     March 25, 2002;

10.  The Registrant's Amended Quarterly Report on Form 10-QSB/A-1 for the fiscal
     year ended March 31, 2001, which the Registrant filed with the Commission
     on March 25, 2002;

11.  The Registrant's Notification of Late Filing on Form 12b-25 with respect to
     its Form 10-KSB for the period ending December 31, 2001, which the
     Registrant filed with the Commission on April 1, 2002;

12.  The Registrant's Current Report on Form 8-K, which the Registrant filed
     with the Commission on May 6, 2002;

13.  The Registrant's Notification of Late Filing on Form 12b-25 with respect to
     its Form 10-QSB for the period ending March 31, 2002, which the Registrant
     filed with the Commission on April 1, 2002;

14.  The Registrant's Quarterly Report on Form 10-QSB for the fiscal quarter
     ended March 31, 2002, which the Registrant filed with the Commission on May
     20, 2002;

15.  The Registrant's Notification of Late Filing on Form 12b-25 with respect to
     its Form 10-QSB for the period ending June 30, 2002, which the Registrant
     filed with the Commission on August 15, 2002;

16.  The Registrant's Quarterly Report on Form 10-QSB for the fiscal quarter
     ended June 30, 2002, which the Registrant filed with the Commission on
     August 19, 2002;

17.  The Registrant's Current Report on Form 8-K, which the Registrant filed
     with the Commission on September 20, 2002;

18.  The Registrant's Notification of Late Filing on Form 12b-25 with respect to
     its Form 10-QSB for the period ending September 30, 2002, which the
     Registrant filed with the Commission on November 18, 2002;

19.  The Registrant's Quarterly Report on Form 10-QSB for the fiscal quarter
     ended September 30, 2002, which the Registrant filed with the Commission on
     November 19, 2002; and

                                      -3-

<PAGE>

20.  All documents that we subsequently file pursuant to Sections 13(a), 13(c),
     14 and 15(d) of the Securities Exchange Act of 1934, prior to our filing of
     a post-effective amendment that indicates that all securities offered by
     this Registration Statement have been sold or which deregisters all such
     securities then remaining unsold, shall be deemed to be incorporated by
     reference into this Registration Statement and to be a part of this
     Registration Statement from the date of filing of such documents.


ITEM  5.  INTERESTS  OF  NAMED  EXPERTS  AND  COUNSEL.

     Wolf,  Rifkin  &  Shapiro,  LLP has given an opinion on the validity of the
common  stock  subject  to  this  Registration  Statement and has provided legal
counsel  to  the  Registrant  in  connection  with  this Registration Statement.
Michael  Wolf  and Daniel Shapiro, partners of such firm, and Ronald Dorfman, an
attorney  of counsel to the firm, have received a total of 150,000 shares of our
common  stock  pursuant to the Plan.  All of those 150,000 shares are covered by
the  Initial Registration Statement.  In addition, such individuals are eligible
to  receive  additional  shares of our common stock pursuant to the Plan, all of
which  shares  will  be  covered  by  the Initial Registration Statement or this
Registration  Statement.


ITEM  8.  EXHIBITS.


5       Opinion regarding legality
23.1    Consent of Shubitz Rosenbloom & Co., P.A.
23.2    Consent of Shubitz Rosenbloom & Co., P.A.
23.3    Consent of Shubitz Rosenbloom & Co., P.A.
23.4    Consent of Shubitz Rosenbloom & Co., P.A.
23.5    Consent of Shubitz Rosenbloom & Co., P.A.
23.6    Consent of Shubitz Rosenbloom & Co., P.A.
23.7    Consent of Shubitz Rosenbloom & Co., P.A.
23.8    Consent of Shubitz Rosenbloom & Co., P.A.
23.9    Consent of Wolf, Rifkin & Shapiro, LLP (included in Exhibit 5)
99      Resolution of Board of Directors

                                      -4-

<PAGE>

                                   SIGNATURES

     Pursuant  to the requirements of the Securities Act of 1933, the Registrant
certifies  that  it  has  reasonable  grounds  to  believe that it meets all the
requirements  for  filing  on  Form  S-8  and  has duly caused this Registration
Statement  to  be  signed  on  its  behalf  by  the  undersigned, thereunto duly
authorized,  in the City of Laguna Hills, State of California, on this 27th day
of December,  2002.

                                   NUWAY  MEDICAL,  INC.

                                        /s/ Dennis Calvert
                                   By:___________________________
                                       Dennis Calvert, President


     Pursuant  to  the requirements of the Securities Act of 1933, this Form S-8
Registration  Statement  has  been  signed  by  the  following  persons  in  the
capacities  and  on  the  dates  indicated:



Dated:  December 27, 2002                /s/ Dennis Calvert
                                         _______________________________
                                         Dennis Calvert, Director, President,
                                         Acting Chief Financial Officer


Dated:  December 27, 2002                /s/ Joseph L. Provenzano
                                         _______________________________
                                         Joseph L. Provenzano, Director







                                      -5-


<PAGE>
                                INDEX TO EXHIBITS


Exhibit No.                 Description

5             Opinion regarding legality
23.1          Consent of Shubitz Rosenbloom & Co., P.A.
23.2          Consent of Shubitz Rosenbloom & Co., P.A.
23.3          Consent of Shubitz Rosenbloom & Co., P.A.
23.4          Consent of Shubitz Rosenbloom & Co., P.A.
23.5          Consent of Shubitz Rosenbloom & Co., P.A.
23.6          Consent of Shubitz Rosenbloom & Co., P.A.
23.7          Consent of Shubitz Rosenbloom & Co., P.A.
23.8          Consent of Shubitz Rosenbloom & Co., P.A.
23.9          Consent of Wolf, Rifkin & Shapiro, LLP (included in Exhibit 5)
99            Resolution of Board of Directors





<PAGE>
[{"type": "S-8", "sequence": "1", "filename": "doc1.txt", "secsgml_size_bytes": 12110}]
{"company-data": {"conformed-name": "NUWAY ENERGY INC", "cik": "0000880242", "assigned-sic": "5500", "irs-number": "650159115", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-102226", "film-number": "02869811"}, "business-address": {"street1": "2000 NE 164TH ST", "city": "NORTH MIAMI BEACH", "state": "FL", "zip": "33162", "phone": "3057561000"}, "mail-address": {"street1": "2000 NE 164TH ST", "city": "N MIAMI BEACH", "state": "FL", "zip": "33162"}, "former-company": [{"former-conformed-name": "REPOSSESSION AUCTION INC", "date-changed": "19940823"}, {"former-conformed-name": "LATIN AMERICAN CASINOS INC", "date-changed": "19960520"}]}
SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM S-8

                        REGISTRATION STATEMENT UNDER THE
                             SECURITIES ACT OF 1933

                               NuWay Medical, Inc.
            --------------------------------------------------------
             (Exact Name of Registrant as Specified in its Charter)

           Delaware                                 65-0159115
-----------------------------------          -------------------------
 (State or Other Jurisdiction of                 (IRS Employer
  Incorporation or  Organization)              Identification No.)

     23461 South Pointe Drive, Suite 200, Laguna Hills, California      92653
--------------------------------------------------------------------------------
     (Address of Principal Executive Offices)                        (Zip Code)

                           2002 Consultant Equity Plan
--------------------------------------------------------------------------------
                            (Full Title of the Plan)

                                 Dennis Calvert
                       23461 South Pointe Drive, Suite 200
                         Laguna Hills, California  92653
--------------------------------------------------------------------------------
                     (Name and Address of Agent for Service)

                                  949.454.9011
--------------------------------------------------------------------------------
          (Telephone Number, Including Area Code, of Agent for Service)

                         CALCULATION OF REGISTRATION FEE
================================================================================

Title  of  Each                     Proposed       Proposed
   Class of                         Maximum        Maximum
  Securities         Amount         Offering      Aggregate         Amount of
    To Be             To Be          Price         Offering       Registration
  Registered        Registered      Per Unit         Price             Fee
--------------------------------------------------------------------------------

Common  Stock       3,500,000(1)    $0.13(2)      $455,000(2)         $126.49
--------------------------------------------------------------------------------

(1)  The  number  of shares of securities covered by this Registration Statement
will  be  increased  as  a  result  of  adjustments  to the registrant's capital
structure  resulting  from  any  future  stock  split, stock dividend or similar
adjustment  to  the  registrant's  outstanding  common  stock.

(2)  Estimated  pursuant  to Rule 457(c) promulgated under the Securities Act of
1933,  as  amended,  solely  for  purpose  of  calculating  the  amount  of  the
registration  fee,  based  upon  the  average  of  the  bid and ask price of the
registrant's  common stock as reported on the NASDAQ Small Capitalization market
reporting  system  on  December  20,  2002.
EXPLANATORY NOTE
                      REGISTRATION OF ADDITIONAL SECURITIES

     NuWay  Medical,  Inc.  (referred  to  as  "We"  or  the  like  or  as the
"Registrant")  is  filing  this  Registration  Statement in order to register an
additional  3,500,000  shares  of  its  common  stock.  We  previously  filed  a
registration  statement  on  Form  S-8  (the  "Initial  Registration Statement")
covering  1,500,000 shares of our common stock that are issuable pursuant to our
2002  Consultant  Equity  Plan  (the  "Plan").  This  amendment  to  the Initial
Registration  Statement  is  being  made  in  order  to  register  an additional
3,500,000  common  shares  that  our  Board of Directors authorized to be issued
under  the  Plan.  As  a  result  of  this  Registration  Statement,  a total of
5,000,000  common  shares  authorized to be issued under the Plan are covered by
filings  we  have  made  on  Form  S-8,  including  this Registration Statement.

     The  contents  of  the  Initial  Registration  Statement,  filed  with  the
Securities  and Exchange Commission (the "Commission") on August 8, 2002, as SEC
file  number  333-97839,  are  incorporated  by reference into this Registration
Statement.

                                     PART II
                           INFORMATION REQUIRED IN THE
                             REGISTRATION STATEMENT

ITEM  3.  INCORPORATION  OF  DOCUMENTS  BY  REFERENCE.

     The  following  documents  are  hereby  incorporated by reference into this
registration  statement:

1.   The Registrant's Annual Report on Form 10-KSB for the fiscal year ended
     December 31, 2001, which the Registrant filed with the Commission on April
     12, 2002;

2.   The Registrant's Current Report on Form 8-K, which the Registrant filed
     with the Commission on January 29, 2002;

3.   The Registrant's Current Report on Form 8-K, which the Registrant filed
     with the Commission on February 22, 2002;

4.   The Registrant's Current Report on Form 8-K, which the Registrant filed
     with the Commission on March 6, 2002;

5.   The Registrant's Current Report on Form 8-K, which the Registrant filed
     with the Commission on March 8, 2002;

6.   The Registrant's Current Report on Form 8-K, which the Registrant filed
     with the Commission on March 12, 2002;

                                      -2-
7.   The Registrant's Amended Annual Report on Form 10-KSB/A-1 for the fiscal
     year ended December 31, 2000, which the Registrant filed with the
     Commission on March 20, 2002;

8.   The Registrant's Amended Quarterly Report on Form 10-QSB/A-1 for the fiscal
     quarter ended September 30, 2001, which the Registrant filed with the
     Commission on March 25, 2002;

9.   The Registrant's Amended Quarterly Report on Form 10-QSB/A-1 for the fiscal
     year ended June 30, 2001, which the Registrant filed with the Commission on
     March 25, 2002;

10.  The Registrant's Amended Quarterly Report on Form 10-QSB/A-1 for the fiscal
     year ended March 31, 2001, which the Registrant filed with the Commission
     on March 25, 2002;

11.  The Registrant's Notification of Late Filing on Form 12b-25 with respect to
     its Form 10-KSB for the period ending December 31, 2001, which the
     Registrant filed with the Commission on April 1, 2002;

12.  The Registrant's Current Report on Form 8-K, which the Registrant filed
     with the Commission on May 6, 2002;

13.  The Registrant's Notification of Late Filing on Form 12b-25 with respect to
     its Form 10-QSB for the period ending March 31, 2002, which the Registrant
     filed with the Commission on April 1, 2002;

14.  The Registrant's Quarterly Report on Form 10-QSB for the fiscal quarter
     ended March 31, 2002, which the Registrant filed with the Commission on May
     20, 2002;

15.  The Registrant's Notification of Late Filing on Form 12b-25 with respect to
     its Form 10-QSB for the period ending June 30, 2002, which the Registrant
     filed with the Commission on August 15, 2002;

16.  The Registrant's Quarterly Report on Form 10-QSB for the fiscal quarter
     ended June 30, 2002, which the Registrant filed with the Commission on
     August 19, 2002;

17.  The Registrant's Current Report on Form 8-K, which the Registrant filed
     with the Commission on September 20, 2002;

18.  The Registrant's Notification of Late Filing on Form 12b-25 with respect to
     its Form 10-QSB for the period ending September 30, 2002, which the
     Registrant filed with the Commission on November 18, 2002;

19.  The Registrant's Quarterly Report on Form 10-QSB for the fiscal quarter
     ended September 30, 2002, which the Registrant filed with the Commission on
     November 19, 2002; and

                                      -3-
20.  All documents that we subsequently file pursuant to Sections 13(a), 13(c),
     14 and 15(d) of the Securities Exchange Act of 1934, prior to our filing of
     a post-effective amendment that indicates that all securities offered by
     this Registration Statement have been sold or which deregisters all such
     securities then remaining unsold, shall be deemed to be incorporated by
     reference into this Registration Statement and to be a part of this
     Registration Statement from the date of filing of such documents.

ITEM  5.  INTERESTS  OF  NAMED  EXPERTS  AND  COUNSEL.

     Wolf,  Rifkin  &  Shapiro,  LLP has given an opinion on the validity of the
common  stock  subject  to  this  Registration  Statement and has provided legal
counsel  to  the  Registrant  in  connection  with  this Registration Statement.
Michael  Wolf  and Daniel Shapiro, partners of such firm, and Ronald Dorfman, an
attorney  of counsel to the firm, have received a total of 150,000 shares of our
common  stock  pursuant to the Plan.  All of those 150,000 shares are covered by
the  Initial Registration Statement.  In addition, such individuals are eligible
to  receive  additional  shares of our common stock pursuant to the Plan, all of
which  shares  will  be  covered  by  the Initial Registration Statement or this
Registration  Statement.

ITEM  8.  EXHIBITS.

5       Opinion regarding legality
23.1    Consent of Shubitz Rosenbloom & Co., P.A.
23.2    Consent of Shubitz Rosenbloom & Co., P.A.
23.3    Consent of Shubitz Rosenbloom & Co., P.A.
23.4    Consent of Shubitz Rosenbloom & Co., P.A.
23.5    Consent of Shubitz Rosenbloom & Co., P.A.
23.6    Consent of Shubitz Rosenbloom & Co., P.A.
23.7    Consent of Shubitz Rosenbloom & Co., P.A.
23.8    Consent of Shubitz Rosenbloom & Co., P.A.
23.9    Consent of Wolf, Rifkin & Shapiro, LLP (included in Exhibit 5)
99      Resolution of Board of Directors

                                      -4-
SIGNATURES

     Pursuant  to the requirements of the Securities Act of 1933, the Registrant
certifies  that  it  has  reasonable  grounds  to  believe that it meets all the
requirements  for  filing  on  Form  S-8  and  has duly caused this Registration
Statement  to  be  signed  on  its  behalf  by  the  undersigned, thereunto duly
authorized,  in the City of Laguna Hills, State of California, on this 27th day
of December,  2002.

                                   NUWAY  MEDICAL,  INC.

                                        /s/ Dennis Calvert
                                   By:___________________________
                                       Dennis Calvert, President

     Pursuant  to  the requirements of the Securities Act of 1933, this Form S-8
Registration  Statement  has  been  signed  by  the  following  persons  in  the
capacities  and  on  the  dates  indicated:

Dated:  December 27, 2002                /s/ Dennis Calvert
                                         _______________________________
                                         Dennis Calvert, Director, President,
                                         Acting Chief Financial Officer

Dated:  December 27, 2002                /s/ Joseph L. Provenzano
                                         _______________________________
                                         Joseph L. Provenzano, Director

                                      -5-
INDEX TO EXHIBITS

Exhibit No.                 Description

5             Opinion regarding legality
23.1          Consent of Shubitz Rosenbloom & Co., P.A.
23.2          Consent of Shubitz Rosenbloom & Co., P.A.
23.3          Consent of Shubitz Rosenbloom & Co., P.A.
23.4          Consent of Shubitz Rosenbloom & Co., P.A.
23.5          Consent of Shubitz Rosenbloom & Co., P.A.
23.6          Consent of Shubitz Rosenbloom & Co., P.A.
23.7          Consent of Shubitz Rosenbloom & Co., P.A.
23.8          Consent of Shubitz Rosenbloom & Co., P.A.
23.9          Consent of Wolf, Rifkin & Shapiro, LLP (included in Exhibit 5)
99            Resolution of Board of Directors